Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy

被引:23
作者
Wang, Shupeng [1 ]
Jin, Shaohua [1 ]
Shu, Qinghai [1 ]
Wu, Song [2 ]
机构
[1] Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China
[2] Shenzhen Univ, Sch Med, Shenzhen 518000, Peoples R China
基金
中国国家自然科学基金;
关键词
intravesical treatment; drug instillation; bladder cancer; bladder penetrating barriers; urothelium; bladder mucosa;
D O I
10.3390/pharmaceutics13020166
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bladder cancer is a significant public health concern and social burden due to its high recurrence risk. Intravesical drug instillation is the primary therapy for bladder cancer to prevent recurrence. However, the intravesical drug therapeutic effect is limited by bladder penetrating barriers. The inadequate intravesical treatment might cause the low drug concentration in lesions, resulting in a high recurrence/progression rate of bladder cancer. Many strategies to get drugs across bladder penetrating barriers have been developed to improve intravesical treatment, including physical and chemical methods. This review summarizes the classical and updated literature and presents insights into great therapeutic potential strategies to overcome bladder penetrating barriers for improving the intravesical treatment of bladder cancer.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 122 条
[11]   EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin [J].
Cambier, Samantha ;
Sylvester, Richard J. ;
Collette, Laurence ;
Gontero, Paolo ;
Brausi, Maurizio A. ;
van Andel, George ;
Kirkels, Wim J. ;
Da Silva, Fernando Calais ;
Oosterlinck, Willem ;
Prescott, Stephen ;
Kirkali, Ziya ;
Powell, Philip H. ;
de Reijke, Theo M. ;
Turkeri, Levent ;
Collette, Sandra ;
Oddens, Jorg .
EUROPEAN UROLOGY, 2016, 69 (01) :60-69
[12]   Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study [J].
Carando, Roberto ;
Zazzara, Michele ;
Cotrufo, Simone ;
Ludovico, Giuseppe M. .
UROLOGIA INTERNATIONALIS, 2019, 103 (03) :285-290
[13]   Bladder filling and voiding affect umbrella cell tight junction organization and function [J].
Carattino, Marcelo D. ;
Prakasam, H. Sandeep ;
Ruiz, Wily G. ;
Clayton, Dennis R. ;
McGuire, Meredith ;
Gallo, Luciana I. ;
Apodaca, Gerard .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (08) :F1158-F1168
[14]  
Chen D, 2003, CLIN CANCER RES, V9, P363
[15]   Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy [J].
Chen, Ting-Yu ;
Tsai, Ming-Jun ;
Chang, Li-Ching ;
Wu, Pao-Chu .
PHARMACEUTICS, 2020, 12 (10) :1-11
[16]   Fluorinated Polymers in Gene Delivery [J].
Cheng, Yi-yun .
ACTA POLYMERICA SINICA, 2017, (08) :1234-1245
[17]   Urease-Powered Polydopamine Nanomotors for Intravesical Therapy of Bladder Diseases [J].
Choi, Hyunsik ;
Cho, Seong Hwi ;
Hahn, Sei Kwang .
ACS NANO, 2020, 14 (06) :6683-6692
[18]   Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis [J].
Chou, Roger ;
Selph, Shelley ;
Buckley, David I. ;
Fu, Rongwei ;
Griffin, Jessica C. ;
Grusing, Sara ;
Gore, John L. .
JOURNAL OF UROLOGY, 2017, 197 (05) :1189-1199
[19]   Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis [J].
Chou, Roger ;
Selph, Shelley ;
Buckley, David I. ;
Fu, Rongwei ;
Griffin, Jessica C. ;
Grusing, Sara ;
Gore, John L. .
JOURNAL OF UROLOGY, 2017, 197 (03) :548-558
[20]   Additivity and the physical basis of multivalency effects: A thermodynamic investigation of the calcium EDTA interaction [J].
Christensen, T ;
Gooden, DM ;
Kung, JE ;
Toone, EJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (24) :7357-7366